Sign in

NCT06471140Enrolling by invitation

Maternal Cardiovascular Adaption to Pregnancy in IVF Patients Following Frozen Embryo Transfer (FET)

MRI Evaluation of Maternal Cardiovascular Response to Pregnancy in IVF Women Following Autologous Natural Cycle FET, Programmed FET and After Donor Embryo Transfer

Source: ClinicalTrials.gov · Last updated 29 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Aim of the study is to explore the effect of a lacking corpus luteum on maternal cardiovascular and metabolic adaption to pregnancy by the use of magnetic resonance imaging (MRI).

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
75 (estimated)
First submitted
18 Jun 2024
Start date
1 Mar 2025
Primary completion date
1 Aug 2027
Lead sponsor
Aalborg University Hospital
NCT number
NCT06471140

What you commit to

  • Study type: Observational
  • Planned participants: 75
  • From 1 Mar 2025 to the primary completion date, 1 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Preelampsia, gestational hypertension, gestational diabetes or severe intrauterine growth restriction (IUGR) in any previous pregnancy

Other illness

  • Essential hypertension
  • Diabetes Mellitus (type 1 or 2)
  • Known cardiac disease
  • Antiphospholipid syndrome, Lupus erythematosus, rheumatoid disease

Other

  • PCOS
  • Smoking
  • Multiple pregnancy
  • Severe claustrophobia or any other contraindications to MRI

Who the study is looking for

  • Autologous embryo transfer in programmed FET-cycle or modified-natural FET-cycle or
  • Planned donor egg transfer in programmed FET-cycle or modified-natural FET-cycle
  • Age < 40 years
  • BMI < 35
  • Primary diagnosis being unexplained infertility, male infertility or tubal factor
  • Singleton blastocyst transfer

Age in the registry: 18 years to 40 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Aalborg University Hospital
Coordinator of this site? Confirm its status
AalborgDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.